Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Kroemer G, Jaattela M . Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005; 5: 886–897.

    Article  CAS  PubMed  Google Scholar 

  2. Droga-Mazovec G, Bojic L, Petelin A, Ivanova S, Romih R, Repnik U et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem 2008; 283: 19140–19150.

    Article  CAS  Google Scholar 

  3. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 2003; 197: 1323–1334.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Puissant A, Colosetti P, Robert G, Cassuto JP, Raynaud S, Auberger P . Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells. Leukemia 2010; 24: 115–124.

    Article  CAS  PubMed  Google Scholar 

  5. Jacquel A, Colosetti P, Grosso S, Belhacene N, Puissant A, Marchetti S et al. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition. Oncogene 2007; 26: 2445–2458.

    Article  CAS  PubMed  Google Scholar 

  6. Thiele DL, Lipsky PE . Apoptosis is induced in cells with cytolytic potential by L-leucyl-L-leucine methyl ester. J Immunol 1992; 148: 3950–3957.

    CAS  PubMed  Google Scholar 

  7. Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC, Linder S . Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 2005; 102: 192–197.

    Article  CAS  PubMed  Google Scholar 

  8. Ivanov A, Beers SA, Walshe CA, Honeychurch J, Alduaij W, Cox KL et al. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J Clin Invest 2009; 119: 2143–2159.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Auberger.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website ()

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Puissant, A., Dufies, M., Raynaud, S. et al. Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells. Leukemia 24, 1099–1101 (2010). https://doi.org/10.1038/leu.2010.55

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.55

This article is cited by

Search

Quick links